“Efficacy and Safety of Abrocitinib Versus Dupilumab in Patients Who Self-Identified As Having Skin of Color: A Post Hoc Analysis of JADE COMPARE”. 2026. SKIN The Journal of Cutaneous Medicine 10 (2): s733. https://doi.org/10.25251/8r6ert44.